Fusion Pharmaceuticals Inc
(FUSN)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 06-2002 | 03-2002 | 12-2001 | 12-2000 | 09-2000 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -10,690 | -3,360 | 520 | -7,420 | N/A |
| Depreciation Amortization | 670 | 180 | 1,320 | -1,900 | N/A |
| Other Working Capital | 12,520 | -2,020 | -4,590 | 9,140 | N/A |
| Other Operating Activity | 4,470 | 2,820 | 1,590 | 1,750 | 0 |
| Operating Cash Flow | $6,970 | $-2,380 | $-1,160 | $1,570 | $N/A |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -2,600 | -1,280 | -2,170 | -820 | N/A |
| Other Investing Activity | -50,470 | 0 | 0 | 0 | 0 |
| Investing Cash Flow | $-53,070 | $-1,280 | $-2,170 | $-820 | $N/A |
| Cash Flows From Financing Activities | |||||
| Other Financing Activity | 26,130 | 25,410 | 21,100 | 1,760 | 0 |
| Financing Cash Flow | $26,130 | $25,410 | $21,100 | $1,760 | $N/A |
| Beginning Cash Position | 24,940 | 24,940 | 7,170 | 0 | N/A |
| End Cash Position | 4,980 | 46,680 | 24,940 | 2,500 | N/A |
| Net Cash Flow | $-19,960 | $21,730 | $17,760 | $2,500 | $N/A |
| Free Cash Flow | |||||
| Operating Cash Flow | 6,970 | -2,380 | -1,160 | 1,570 | N/A |
| Free Cash Flow | 6,970 | -2,380 | -1,160 | 1,570 | 0 |